Biodexa Pharmaceuticals Plc Operating Income

Biodexa Pharmaceuticals Plc (BDRX) currently reports a operating income of $-16M as of December 2025. That compares with $-6.6M in the prior-year period — down 140.1% year over year. Use the charts on this page to explore Biodexa Pharmaceuticals Plc's operating income history and peer comparisons.

Biodexa Pharmaceuticals Plc's operating income decreased from $-6.6M to $-16M — a 140.1% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biodexa Pharmaceuticals Plc reported $-16M in operating income as of December 2025. That compares with $-6.6M in the prior-year period — down 140.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-16M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biodexa Pharmaceuticals Plc, and consider following BDRX for alerts when major investors trade the stock.

Biodexa Pharmaceuticals Plc is classified in the Healthcare sector. On operating income, it currently shows $-16M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BDRX with unrelated industries.